英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
2524查看　2524　在百度字典中的解释百度英翻中〔查看〕
2524查看　2524　在Google字典中的解释Google英翻中〔查看〕
2524查看　2524　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home | Harrow, Inc.
    The Investor Relations website contains information about Harrow, Inc 's business for stockholders, potential investors, and financial analysts
  • About | Harrow, Inc.
    The Investor Relations website contains information about Harrow, Inc 's business for stockholders, potential investors, and financial analysts
  • News - Harrow, Inc.
    The Investor Relations website contains information about Harrow, Inc 's business for stockholders, potential investors, and financial analysts
  • Careers | Harrow, Inc.
    The Investor Relations website contains information about Harrow, Inc 's business for stockholders, potential investors, and financial analysts
  • Harrow Announces Pricing of $50. 0 Million Offering of Senior Unsecured . . .
    NASHVILLE, Tenn , March 24, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the pricing of its private offering (the “Offering”) of $50 0 million aggregate principal amount of 8 625% senior unsecured notes due 2030 (the “2030 Notes”) The 2030 Notes will be guaranteed on a senior unsecured
  • Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making . . .
    NASHVILLE, Tenn -- (BUSINESS WIRE)--Jan 27, 2025-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced the launch of its “Harrow Cares” program through a strategic partnership with Cencora (NYSE: COR) Harrow Cares delivers a comprehensive suite of high‑quality access and affordability services, enhancing support for retina specialists, their
  • Pipeline | Harrow, Inc.
    Harrow advances its pipeline through a disciplined, capital-efficient development strategy that prioritizes risk management and speed to market By selectively investing in assets with reduced clinical and regulatory uncertainty and executing with a streamlined operational model, Harrow efficiently progresses products toward approval and commercialization, supporting sustainable growth and
  • Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic . . .
    Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0 1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
  • Harrow to Acquire Melt Pharmaceuticals
    Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes For more information about Harrow, please visit harrow com About Melt Pharmaceuticals
  • Harrow Enters into Commercialization Agreement with Samsung Bioepis for . . .
    Harrow to assume full commercial responsibility for BYOOVIZ ® and OPUVIZ™ by the end of 2025 NASHVILLE --(BUSINESS WIRE)--Jul 17, 2025-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it has entered into a definitive agreement with Samsung





中文字典-英文字典  2005-2009